Mohamed F Doheim: Bridging Therapy Improves Outcomes in M2 MCA Occlusions
Mohamed F Doheim, Faculty Instructor (Research) at NIH StrokeNet, shared a post on X:
”Proud to share our new study in Stroke AHA/ASA. In patients with M2 MCA occlusions, bridging therapy (IVT+EVT) was associated with better 90-day functional outcomes compared to EVT alone, with no major safety concerns.”
Read the full article here.
Title: Direct Endovascular Versus Bridging Therapy in M2 Segment Occlusion of Middle Cerebral Artery: A MR CLEAN Registry Study
Authors: Mohamed F. Doheim, Robrecht R.M.M. Knapen, Julie Staals, Wouter J. Schonewille, Diederik W.J. Dippel, Adriaan C.G.M. van Es, Hester F. Lingsma, Christiaan van der Leij, Charles B. Majoie, Raul G. Nogueira, Robert J. van Oostenbrugge, Wim H. van Zwam
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology